Search
for
Sort by
Research 61–90 of 1000+
- Polymeric Nanohydrogel in Topical Drug Delivery System
- Psoriasiform drug eruption to finasteride: Uncommon side effect of a commonly used drug
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014
- Dermatologic Side Effects of Psychotropic Medications
- Drug-induced skin reactions: a pathologist viewpoint
- Dermatological Drugs, Topical Agents, and Cosmetics
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Oral Presentations
- A case of eruptive lichen spinulosus after toxic epidermal necrolysis
- The pharmacology of methotrexate
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy
- Winding the clock back on female androgenetic alopecia
- Contents
- Contents
- Contents
- Dermatolojik Problemler ve COVID-19
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Drug Reactions Affecting Hair: Diagnosis
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Adverse cutaneous reactions to soft tissue fillers – a review of the histological features
- 392 Hair loss after drug reaction with eosinophilia and systemic symptoms: A multicentric retrospective study
- Methotrexate/tacrolimus/voriconazole